Literature DB >> 15574347

Citrullinated proteins in rheumatoid arthritis.

Ryo Yamada1, Akari Suzuki, Xiaotian Chang, Kazuhiko Yamamoto.   

Abstract

Citrullinated proteins that are produced by enzymatic deimination of arginine residues in proteins by peptidylarginine deiminases (PADIs) are of particular interest in the pathogenesis of rheumatoid arthritis (RA). First, peptidylarginine deiminase type 4 (PADI4) gene, which codes one of the PADI enzyme isotypes, has a genetic variant that increases susceptibility to RA. The RA-susceptible variant of PADI4 seems to increase the risk of RA by increasing its enzymatic activity. Second, this post-translational protein modification unfolds proteins by loss of a positive charge in arginine residues, with a subsequent change in antigenicity of the self-proteins. Third, these citrullinated proteins are recognized by anti-citrullinated peptide antibodies that are the most RA-specific autoantibodies. Finally, the expression of the PADI enzyme, citrullination of proteins, and production of anti-citrullinated protein antibodies occur in synovium. These data suggest that citrullination of proteins by PADI is related to alteration of antigenicity of peptides and very closely linked to pathogenesis of RA autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15574347     DOI: 10.2741/1506

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  24 in total

1.  Role of lymphotoxin and homeostatic chemokines in the development and function of local lymphoid tissues in the respiratory tract.

Authors:  Javier Rangel-Moreno; Damian Carragher; Troy D Randall
Journal:  Inmunologia       Date:  2007

Review 2.  The quest for better understanding of HLA-disease association: scenes from a road less travelled by.

Authors:  Joseph Holoshitz
Journal:  Discov Med       Date:  2013-09       Impact factor: 2.970

3.  Anti-cyclic citrullinated peptide antibody in rheumatic diseases other than rheumatoid arthritis.

Authors:  Toshihiro Matsui; Kota Shimada; Shigeto Tohma
Journal:  Clin Rheumatol       Date:  2005-11-10       Impact factor: 2.980

4.  Expression and citrullination of keratin in synovial tissue of rheumatoid arthritis.

Authors:  Xiaotian Chang; Xiangdong Jian; Xinfeng Yan
Journal:  Rheumatol Int       Date:  2009-02-05       Impact factor: 2.631

5.  Recognition of new citrulline-containing peptide epitopes by autoantibodies produced in vivo and in vitro by B cells of rheumatoid arthritis patients.

Authors:  Eszter Szarka; Fruzsina Babos; Anna Magyar; Krisztina Huber; Zoltán Szittner; Krisztián Papp; József Prechl; Judit Pozsgay; Zsuzsa Neer; Monika Ádori; György Nagy; Bernadette Rojkovich; Tamás Gáti; Judit Kelemen; Zsuzsanna Baka; Márta Brózik; Borbála Pazár; Gyula Poór; Ferenc Hudecz; Gabriella Sármay
Journal:  Immunology       Date:  2014-02       Impact factor: 7.397

6.  Inducible bronchus-associated lymphoid tissue (iBALT) in patients with pulmonary complications of rheumatoid arthritis.

Authors:  Javier Rangel-Moreno; Louise Hartson; Carmen Navarro; Miguel Gaxiola; Moises Selman; Troy D Randall
Journal:  J Clin Invest       Date:  2006-12       Impact factor: 14.808

Review 7.  An interplay of structure and intrinsic disorder in the functionality of peptidylarginine deiminases, a family of key autoimmunity-related enzymes.

Authors:  Mohammed Alghamdi; Khaled A Al Ghamdi; Rizwan H Khan; Vladimir N Uversky; Elrashdy M Redwan
Journal:  Cell Mol Life Sci       Date:  2019-07-24       Impact factor: 9.261

8.  Are there autoantibodies reacting against citrullinated peptides derived from type I and type II collagens in patients with rheumatoid arthritis?

Authors:  M-K Koivula; S Aman; A Karjalainen; M Hakala; J Risteli
Journal:  Ann Rheum Dis       Date:  2005-10       Impact factor: 19.103

9.  Autoantibodies binding to citrullinated telopeptide of type II collagen and to cyclic citrullinated peptides predict synergistically the development of seropositive rheumatoid arthritis.

Authors:  Marja-Kaisa Koivula; Markku Heliövaara; Jarmo Ramberg; Paul Knekt; Harri Rissanen; Timo Palosuo; Juha Risteli
Journal:  Ann Rheum Dis       Date:  2007-05-01       Impact factor: 19.103

10.  Peptidylarginine deiminase 2 (PAD2) overexpression in transgenic mice leads to myelin loss in the central nervous system.

Authors:  Abdiwahab A Musse; Zhen Li; Cameron A Ackerley; Dorothee Bienzle; Helena Lei; Roberto Poma; George Harauz; Mario A Moscarello; Fabrizio G Mastronardi
Journal:  Dis Model Mech       Date:  2008-11-06       Impact factor: 5.758

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.